FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling-Reference-Cited by-同舟云学术

FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling

Published:2017-11 Issue:5 Volume:9 Page:1423-1431
ISSN:2213-6711
Container-title:Stem Cell Reports
language:en
Short-container-title:Stem Cell Reports

Author:

Arias-Fuenzalida Jonathan,Jarazo Javier,Qing Xiaobing,Walter Jonas,Gomez-Giro Gemma,Nickels Sarah Louise,Zaehres Holm,Schöler Hans Robert,Schwamborn Jens Christian

Funder

LCSB Pluripotent Stem Cell Core Facility

FNR

NCL-Stiftung

Fondation du Pelican de Mie et Pierre Hippert-Faber

European Union's Horizon 2020 Research and Innovation Program

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,Genetics,Biochemistry

Reference28 articles.

1. The function of alpha-synuclein;Bendor;Neuron,2013

2. Genetic assessment of familial and early-onset Parkinson's disease in a Greek population;Bozi;Eur. J. Neurol.,2014

3. Parkinson's disease as a system-level disorder;Caligiore;NPJ Parkinsons Dis.,2016

4. Enhanced plating efficiency of trypsin-adapted human embryonic stem cells is reversible and independent of trisomy 12/17;Chan;Cloning Stem Cells,2008

5. Parkinson's disease induced pluripotent stem cells with triplication of the alpha-synuclein locus;Devine;Nat. Commun.,2011

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders;Current Gene Therapy;2025-02

2. In vivo and ex vivo gene therapy for neurodegenerative diseases: a promise for disease modification;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-22

3. Development of pathophysiologically relevant models of sickle cell disease and β-thalassemia for therapeutic studies;Nature Communications;2024-02-27

4. The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson’s Disease: a New Genetic State of the Art;Molecular Neurobiology;2024-02-13

5. Exosomes for CRISPR-Cas9 Delivery: The Cutting Edge in Genome Editing;Molecular Biotechnology;2023-11-27